LifeBlood: We talked about psychedelics and mental health, the current state of depression and anxiety in the United States, the challenges in bringing a new therapeutic to the market, and the impact psilocybin can have on our health, with Doug Drysdale, CEO of Cybin. Listen to learn about the human brain’s neuroplasticity and how it can be changed! You can learn more about Doug at Cybin.com, Facebook, X, Instagram, and Linkedin. This video was conducted on behalf of Cybin, and was funded by Gold Standard Media LLC and/or affiliates. For our full disclaimer, please visit: https://portal.goldstandardir.com/disclaimer/CYBN-180 https://ir.cybin.com/overview/default.aspx NYSE: CYBN I CBOE: CYBN Thanks, as always for listening! If you got some value and enjoyed the show, please leave us a review here: https://ratethispodcast.com/lifebloodpodcast You can learn more about us at LifeBlood.Live, Twitter, LinkedIn, Instagram, YouTube and Facebook or you’d like to be a guest on the show, contact us at [email protected]. Stay up to date by getting our monthly updates. Want to say “Thanks!” You can buy us a cup of coffee. https://www.buymeacoffee.com/lifeblood

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related